Title
Category
Credits
Event date
Cost
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.50 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
In this webinar, Jared Lowe, MD, HMDC dicusses serious illness and discuss strategies to support patients with a primary focus on reviewing the services of palliative care and hospice care.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Webinar InformationWebinar Description
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
William Wood, MD, MPH will review ways to expand traditional clinic-based cancer navigation to population-based cancer navigation using a central navigation approach. We will discuss how this approach can foster equity in care delivery and outcomes, while incorporating new initiatives that promote quality improvement. We will also talk about how this work fits into the current national environment that surrounds cancer navigation, including the recent development of a learning community and of new proposed billing codes that support the delivery of navigation services.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Symptom burden is high in thoracic surgery and oncology patients. Gita Mody, MD, MPH discusses the role of electronic patient-reported outcome (ePRO) remote monitoring systems to improve patients' survivorship care.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Sonali Acharya, PharmD. will explain the role of specialty pharmacies. We will discuss accreditation requirements for specialty pharmacies, process to determine which medications are considered specialty and specifically the benefits of a healthcare system specialty pharmacy.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Dr. Nakamura will present on key topics related to cognitive issues experienced by patients with cancer.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Cancer patients and survivors have higher rates of anxiety and depression compared to the general population. Cancer-related anxiety and depression may significantly reduce wellbeing and result in adverse treatment and survival outcomes. This lecture will provide an overview of psychotherapeutic modalities that can treat cancer-related distress.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Yuri Fedoriw, MD, provides a general background of cancer pathology and tissue diagnosis. The development of testing methods and their application will be discussed, as will the limitations and challenges of cancer classification.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Samuel Cykert, MD, and Christina Yongue, MPH, MCHES, describe the long-lasting racial disparities in breast and lung cancer care, and some of the root causes for these inequities. Participants will learn how a community-academic-medical partnership addressed these disparities by designing system-change interventions based on antiracism principles.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Farrell Wiggins MS, OTR/L, and Alexis Petteway, MS, OTR/L, provide insight into Occupational Therapy’s unique role in cancer rehabilitation. They explore the benefits of receiving OT in both the inpatient and outpatient settings. Importantly, they also discuss the how occupational therapists measure and address cancer and chemotherapy related symptoms and occupational challenges in cancer survivors.

Pages